PERRIGO Co plc financial data

Symbol
PRGO on NYSE
Industry
Pharmaceutical Preparations
Location
The Sharp Building, Hogan Place, Dublin 2, Ireland
State of incorporation
Ireland
Fiscal year end
December 31
Former names
PERRIGO Co Ltd (to 11/12/2013)
Latest financial report
10-K - Q4 2024 - Feb 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 216 % -7.93%
Quick Ratio 80.4 % -17.9%
Debt-to-equity 131 % +3.61%
Return On Equity -0.16 %
Return On Assets -1.64 % -1301%
Operating Margin 2.58 % -20.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 136M shares +0.1%
Common Stock, Shares, Outstanding 137M shares +0.74%
Entity Public Float 3.5B USD -23.8%
Common Stock, Value, Issued 6.73B USD -1.52%
Weighted Average Number of Shares Outstanding, Basic 137M shares +1.55%
Weighted Average Number of Shares Outstanding, Diluted 137M shares +1.55%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 4.37B USD -6.06%
Research and Development Expense 112M USD -8.41%
Selling and Marketing Expense 547M USD -14.8%
General and Administrative Expense 468M USD -10.4%
Operating Income (Loss) 113M USD -25.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 21.8M USD +13.5%
Income Tax Expense (Benefit) 80M USD
Net Income (Loss) Attributable to Parent -172M USD -1253%
Earnings Per Share, Basic -1.25 USD/shares -1289%
Earnings Per Share, Diluted -1.25 USD/shares -1289%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.46B USD +145%
Accounts Receivable, after Allowance for Credit Loss, Current 642M USD -13.2%
Inventory, Net 1.08B USD -5.18%
Assets, Current 2.48B USD -12.4%
Deferred Income Tax Assets, Net 5.1M USD -80.2%
Property, Plant and Equipment, Net 918M USD +0.15%
Operating Lease, Right-of-Use Asset 175M USD -4.58%
Intangible Assets, Net (Excluding Goodwill) 4.5B USD -9.99%
Goodwill 3.32B USD -5.92%
Other Assets, Noncurrent 319M USD -4.95%
Assets 9.65B USD -10.7%
Accounts Payable, Current 495M USD +3.66%
Employee-related Liabilities, Current 123M USD -2.99%
Accrued Liabilities, Current 227M USD -13.5%
Liabilities, Current 1.04B USD -34.2%
Deferred Income Tax Liabilities, Net 203M USD -22.5%
Operating Lease, Liability, Noncurrent 154M USD -3.63%
Other Liabilities, Noncurrent 499M USD -10.8%
Liabilities 5.33B USD -11.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -162M USD -1618%
Retained Earnings (Accumulated Deficit) -2.25B USD -8.26%
Stockholders' Equity Attributable to Parent 4.32B USD -9.41%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 4.69B USD -3.04%
Liabilities and Equity 9.65B USD -10.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.4M USD -107%
Net Cash Provided by (Used in) Financing Activities -60.4M USD -19.1%
Net Cash Provided by (Used in) Investing Activities -23.5M USD -19.9%
Common Stock, Shares Authorized 10B shares 0%
Common Stock, Shares, Issued 137M shares +0.74%
Common Stock, Par or Stated Value Per Share 0 EUR/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -92.8M USD -94.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 559M USD -25.6%
Deferred Tax Assets, Valuation Allowance 489M USD +10.8%
Operating Lease, Liability 182M USD -2.94%
Payments to Acquire Property, Plant, and Equipment 25.1M USD +8.19%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 43M USD
Lessee, Operating Lease, Liability, to be Paid 214M USD -0.79%
Operating Lease, Liability, Current 27.8M USD +1.09%
Lessee, Operating Lease, Liability, to be Paid, Year Two 28.3M USD -5.03%
Lessee, Operating Lease, Liability, to be Paid, Year One 33.4M USD +2.45%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure +31.5%
Deferred Income Tax Expense (Benefit) -11M USD -11.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 32.2M USD +13.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 26.2M USD +10.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 240M USD +0.13%
Lessee, Operating Lease, Liability, to be Paid, Year Four 19.3M USD -13.5%
Operating Lease, Payments 8.5M USD -5.56%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 229M USD -14%
Depreciation, Depletion and Amortization 81.4M USD -8.23%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%